Table 3.
Characteristic | Good (n = 78) | Intermediate (n = 19) | Poor (n = 16) | Total (n =113) |
---|---|---|---|---|
Age groups (years) | ||||
8-12 | 22 (56.4%) | 9 (23.1%) | 8 (20.5%) | 39 (100.0%) |
13-18 | 56 (75.7%) | 10 (13.5%) | 8 (10.8%) | 74 (100.0%) |
Gender | ||||
Male | 51 (85.0%) | 5 (8.3%) | 4 (6.7%) | 60 (100.0%) |
Female | 27 (50.9%) | 14 (26.4%) | 12 (22.7%) | 53 (100.0%) |
Orphan status | ||||
One/both parents alive | 71 (68.3%) | 18 (17.3%) | 15 (14.4%) | 104 (100.0%) |
Double orphan | 7 (77.8%) | 1 (11.1%) | 1 (11.1%) | 9 (100.0%) |
ART | ||||
First line | 55 (67.9%) | 12 (14.8%) | 14 (17.3%) | 81 (100.0%) |
Second line | 23 (71.9%) | 7 (21.9%) | 2 (6.2%) | 32 (100.0%) |
Duration of ART | ||||
≤ 60 months | 6 (37.5%) | 4 (25.0%) | 6 (37.5%) | 16 (100.0%) |
>6 0months | 72 (74.2%) | 15 (15.5%) | 10 (10.3%) | 97 (100.0%) |
Viral load (copies/ml) | ||||
<1000 | 66 (72.5%) | 14 (15.4%) | 11 (12.1%) | 91 (100.0%) |
≥1000 | 12 (54.5%) | 5 (22.7%) | 5 (22.7%) | 22 (100.0%) |
CD4 count (cells/µL) | ||||
≥500 | 63 (70.8%) | 12 (13.5%) | 14 (15.7%) | 89 (100.0%) |
<500 | 15 (62.5%) | 7 (29.2%) | 2 (8.3%) | 24 (100.0%) |